Navigation Links
Cumberland Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 3, 2011
Date:10/13/2011

NASHVILLE, Tenn., Oct. 13, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it will release third quarter 2011 financial results after the market closes on Thursday, November 3, 2011. A conference call and live Internet webcast will be held on Thursday, November 3, 2011, at 5:00 p.m. Eastern Time to discuss the results.

To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers). The Conference ID for the rebroadcast is 18137911. The live webcast and rebroadcast can be accessed via Cumberland's website at http://investor.shareholder.com/cpix/events.cfm.

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include Acetadote® (acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor® (ibuprofen) Injection, the first injectable treatment for pain and fever approved in the United States, and Kristalose® (lactulose) for Oral Solution, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information on Cumberland, please visit the Company's website at www.cumberlandpharma.com.


'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer
2. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference In New York
3. Cumberland Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference in Boston
4. Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results
5. Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America
6. Cumberland Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
7. Cumberland Pharmaceuticals to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
8. Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results
9. Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
10. Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
11. Cumberland Pharmaceuticals Appoints Rick S. Greene as Vice President, Finance & Accounting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
(Date:1/23/2015)... , January 23, 2015 Heptares Therapeutics, ... delighted to announce that the Malcolm Campbell Memorial ... (Vice President of Chemistry), Fiona Marshall (Chief ... Executive Officer and co-founder) for the seminal contributions to GPCR ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... PETALUMA, Calif., Oct. 8 Oculus Innovative,Sciences, Inc. (Nasdaq: ... be,presenting at the 4th Annual BIO InvestorForum Conference to ... San Francisco. The company,s,president and chief executive officer, Hoji ... its clinical programs and the most recent,quarter on Thursday, ...
... A research study,at the University of Arkansas for Medical Sciences ... rapidly assembled groups of women to,aid in the study of ... collection of saliva samples from,thousands of women and is being ... Komen for the Cure. The saliva samples will be used ...
Cached Medicine Technology:Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference 2Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research 2
(Date:1/22/2015)... 22, 2015 Liberty University has received accreditation ... program from the Council for Accreditation of Counseling & ... Liberty’s Center for Counseling & Family Studies , is ... the university’s new School of Behavioral Sciences. Prior to the ...
(Date:1/22/2015)... 22, 2015 Woodloch Pines, an all-inclusive ... selected by TripAdvisor as the number one best large hotel ... in the world for their annual Travelers’ Choice Awards. ... . The website is home to millions of unbiased and ...
(Date:1/22/2015)... 23, 2015 VogueQueen is a seasoned and ... and many designers are thrilled to have it lead the ... its new collection of prom dresses for the global market. ... the strategic vision and he focuses on continuing the goal ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... since the 2003,ruling by the Federal Social Court ... German surgeons have performed a cross over transplantation very recently ... the procedure legal in certain circumstances. ,In a cross ... or her kidney to the ill person in another couple, ...
... from persistence of REM activity, including typical paralysis associated// ... become aware or as they are falling asleep. ... surroundings, but are unable to move. Hallucinations, such as ... chest, and hearing footsteps or odd sounds commonly accompany ...
... big or growing fast: systematic review of size and ... those who grow rapidly during the first two years of ... adulthood, a study reveals. ,There is an urgent need ... it is not clear how early in life prevention could ...
... Richard Gere with many Kollywood stars like Kamal Hassan, ... a show in Hyderabad to spread the awareness on AIDS. ... sponsored by agencies including the Melinda and Bill Gates Foundation ... ,'You can change anything in partnership with others. I ...
... proximity of the thyroid gland to the larynx, trachea, ... these structures. Invasion of the larynx by differentiated thyroid ... mortality when present. ,A recent article, which appears ... of Surgery , reports on 5 differentiated thyroid carcinomas ...
... Viagra use is linked to development of vision disorders. It ... used Viagra medicines. It is found that it contains three ... of blindness. Men most at risk for the vision loss ... high blood pressure and high cholesterol, among other ailments. The ...
Cached Medicine News:Health News:First Crossover Kidney Transplantation In Germany 2Health News:First Crossover Kidney Transplantation In Germany 3Health News:Isolated Sleep Paralysis In Patients With Anxiety Disorders 2Health News:Impotence drug such as Viagra may cause Vision Loss 2
...
The PICO50 is used for arterial line sampling....
The PICO70 is a self-filling sampler for arterial puncture....
... never handled like this before. ... mind, the Spiroflex catheters unique ... and hydrophilic coating provide outstanding ... in with ease and track ...
Medicine Products: